AGIO Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.93%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $2,110,887.90

Agios Pharmaceuticals Insider Trading History Chart

Agios Pharmaceuticals Share Price & Price History

^$59.10

▲ +1.59 (2.76%)

As of 11/26/2024 01:00 AM ET

Days: 30 | 90 | 365

Trump’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

YES, I WANT THE #1 CRYPTO NOW

Agios Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/26/2024	Cecilia Jones	CFO	Sell	2,542	$49.03	$124,634.26	20,158
8/8/2024	Brian Goff	CEO	Sell	11,091	$42.75	$474,140.25	78,792
4/10/2024	Jacqualyn A. Fouse	Director	Sell	7,791	$27.55	$214,642.05	137,396
3/5/2024	Brian Goff	CEO	Sell	4,156	$32.57	$135,360.92	53,780
3/5/2024	James William Burns	Insider	Sell	2,642	$32.57	$86,049.94	34,518
3/5/2024	Kaye I Foster-Cheek	Director	Sell	300	$32.21	$9,663.00	11,224
2/20/2024	Theodore James Jr. Washburn	Insider	Sell	504	$26.63	$13,421.52	2,741
2/14/2024	Sarah Gheuens	Insider	Sell	642	$25.14	$16,139.88	33,431
1/24/2024	Brian Goff	CEO	Sell	7,635	$21.64	$165,221.40	49,436
1/24/2024	Cecilia Jones	CFO	Sell	1,886	$21.64	$40,813.04	13,069
1/24/2024	Jacqualyn A. Fouse	Director	Sell	10,722	$21.64	$232,024.08	129,253
1/24/2024	James William Burns	Insider	Sell	1,708	$21.64	$36,961.12	30,378
1/9/2024	Brian Goff	CEO	Sell	12,066	$22.99	$277,397.34	40,053
1/9/2024	Jacqualyn A. Fouse	Director	Sell	8,391	$22.99	$192,909.09	116,075
1/9/2024	James William Burns	Insider	Sell	1,163	$22.99	$26,737.37	26,336
1/5/2024	Tsveta Milanova	Insider	Sell	2,902	$22.32	$64,772.64	9,404
9/28/2023	Cecilia Jones	CFO	Sell	2,179	$24.79	$54,017.41	9,575
8/17/2023	James William Burns	Insider	Sell	6,395	$26.28	$168,060.60	23,890
8/9/2023	Kaye I Foster-Cheek	Director	Sell	25,000	$25.96	$649,000.00	11,524
8/7/2023	Theodore James Jr. Washburn	Insider	Sell	2,918	$25.39	$74,088.02	2,741
8/1/2023	Theodore James Jr. Washburn	Insider	Sell	1,232	$26.26	$32,352.32	5,659
6/30/2023	Brian Goff	CEO	Sell	11,449	$28.36	$324,693.64	14,079
6/30/2023	Cecilia Jones	CFO	Sell	1,597	$28.36	$45,290.92	3,783
6/30/2023	Jacqualyn A. Fouse	Director	Sell	10,718	$28.36	$303,962.48	106,966
6/30/2023	James William Burns	Insider	Sell	1,707	$28.36	$48,410.52	30,285
4/3/2023	David P Schenkein	Director	Sell	16,363	$22.85	$373,894.55	117,879
3/27/2023	David P Schenkein	Director	Sell	20,000	$22.15	$443,000.00	117,879
3/13/2023	David P Schenkein	Director	Sell	20,000	$22.49	$449,800.00	117,879
3/3/2023	Theodore James Jr. Washburn	Insider	Sell	504	$24.29	$12,242.16	2,741
2/16/2023	Theodore James Jr. Washburn	Insider	Sell	233	$27.21	$6,339.93	2,668
2/13/2023	David P Schenkein	Director	Sell	20,000	$28.62	$572,400.00	117,879
1/30/2023	David P Schenkein	Director	Sell	20,000	$29.33	$586,600.00	117,879
1/17/2023	David P Schenkein	Director	Sell	20,000	$28.85	$577,000.00	117,879
2/25/2022	Theodore James Jr. Washburn	Insider	Sell	108	$30.00	$3,240.00
2/16/2022	Theodore James Jr. Washburn	Insider	Sell	233	$30.81	$7,178.73
2/14/2022	Theodore James Jr. Washburn	Insider	Sell	504	$31.25	$15,750.00

Unveiled: NVIDIA’s "Secret Royalty" Program

From Behind the Markets | Ad

Did you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?

Click Here to learn how to get in now >>>

SEC Filings (Institutional Ownership Changes) for Agios Pharmaceuticals (NASDAQ:AGIO)

Institutional Buying and Selling by Quarter

Agios Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/25/2024	Tidal Investments LLC	21,827	$0.97M	0.0%	-3.3%	0.038%
11/16/2024	Geode Capital Management LLC	1,357,531	$60.33M	0.0%	+0.5%	2.380%
11/15/2024	Frazier Life Sciences Management L.P.	1,044,154	$46.39M	1.9%	+19.7%	1.831%
11/15/2024	XTX Topco Ltd	8,329	$0.37M	0.0%	+56.2%	0.015%
11/15/2024	Wellington Management Group LLP	29,448	$1.31M	0.0%	-19.1%	0.052%
11/15/2024	State Street Corp	2,331,433	$103.59M	0.0%	+10.2%	4.088%
11/15/2024	Parkman Healthcare Partners LLC	285,099	$12.67M	1.6%	-36.1%	0.500%
11/15/2024	ArrowMark Colorado Holdings LLC	882,731	$39.22M	0.5%	-13.4%	1.548%
11/15/2024	Erste Asset Management GmbH	2,184,900	$97.20M	1.2%	N/A	3.831%
11/14/2024	Bellevue Group AG	3,735,915	$165.99M	2.7%	-3.7%	6.551%
11/14/2024	Caligan Partners LP	579,717	$25.76M	8.2%	+12.6%	1.017%
11/14/2024	PDT Partners LLC	56,735	$2.52M	0.2%	-24.6%	0.099%
11/14/2024	Verition Fund Management LLC	7,097	$0.32M	0.0%	N/A	0.012%
11/14/2024	Vestal Point Capital LP	760,000	$33.77M	2.6%	N/A	1.333%
11/14/2024	Summit Partners Public Asset Management LLC	101,730	$4.52M	0.1%	N/A	0.178%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	113,229	$5.03M	0.0%	-9.8%	0.199%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	12,132	$0.54M	0.0%	+6.0%	0.021%
11/13/2024	BNP Paribas Financial Markets	11,946	$0.53M	0.0%	+15.1%	0.021%
11/13/2024	Quantbot Technologies LP	3,284	$0.15M	0.0%	N/A	0.006%
11/13/2024	FMR LLC	45,393	$2.02M	0.0%	+283.2%	0.080%
11/13/2024	The Manufacturers Life Insurance Company	143,431	$6.37M	0.0%	+4.1%	0.252%
11/13/2024	Loomis Sayles & Co. L P	612,366	$27.21M	0.0%	+36.4%	1.074%
11/13/2024	Fisher Asset Management LLC	855,328	$38M	0.0%	+20.5%	1.500%
11/12/2024	Algert Global LLC	37,356	$1.66M	0.0%	-7.2%	0.066%
11/12/2024	Charles Schwab Investment Management Inc.	465,620	$20.69M	0.0%	+1.8%	0.816%
11/9/2024	Intech Investment Management LLC	20,078	$0.89M	0.0%	N/A	0.035%
11/8/2024	BNP PARIBAS ASSET MANAGEMENT Holding S.A.	907,044	$40.30M	0.1%	-0.5%	1.590%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	22,273	$0.99M	0.0%	-40.3%	0.039%
11/8/2024	Commerce Bank	6,069	$0.27M	0.0%	-2.7%	0.011%
11/7/2024	Quest Partners LLC	2,202	$98K	0.0%	+139.6%	0.004%
11/4/2024	State of New Jersey Common Pension Fund D	42,593	$1.89M	0.0%	-13.0%	0.075%
11/1/2024	Atria Investments Inc	10,628	$0.47M	0.0%	+47.4%	0.019%
10/29/2024	Harbor Capital Advisors Inc.	39,090	$1.74M	0.1%	+19.3%	0.069%
10/28/2024	Oak Ridge Investments LLC	40,378	$1.79M	0.2%	+14.6%	0.071%
10/25/2024	China Universal Asset Management Co. Ltd.	10,942	$0.49M	0.1%	+64.0%	0.019%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	2,058	$94K	0.0%	+21.4%	0.004%
10/23/2024	Assenagon Asset Management S.A.	7,409	$0.33M	0.0%	-94.5%	0.013%
10/11/2024	Creative Planning	15,640	$0.70M	0.0%	+35.8%	0.027%
10/10/2024	Inspire Investing LLC	9,228	$0.41M	0.0%	+13.7%	0.016%
10/8/2024	CWM LLC	2,167	$96K	0.0%	+554.7%	0.004%
10/5/2024	Handelsbanken Fonder AB	17,823	$0.79M	0.0%	+10.5%	0.031%
10/3/2024	SG Americas Securities LLC	15,864	$0.71M	0.0%	N/A	0.028%
8/16/2024	Creative Planning	11,520	$0.50M	0.0%	+24.6%	0.020%
8/16/2024	Algert Global LLC	40,256	$1.74M	0.1%	-5.0%	0.071%
8/16/2024	Frazier Life Sciences Management L.P.	871,974	$37.60M	1.8%	+66.7%	1.536%
8/15/2024	Scientech Research LLC	17,592	$0.76M	0.2%	N/A	0.031%
8/15/2024	The Manufacturers Life Insurance Company	137,844	$5.94M	0.0%	+54.9%	0.243%
8/15/2024	D. E. Shaw & Co. Inc.	678,234	$29.25M	0.0%	+87.3%	1.195%
8/15/2024	AQR Capital Management LLC	33,164	$1.43M	0.0%	+196.5%	0.058%
8/15/2024	Armistice Capital LLC	2,079,151	$89.65M	1.1%	-29.9%	3.662%
8/15/2024	AXA S.A.	238,682	$10.29M	0.0%	-10.1%	0.420%
8/15/2024	Caxton Associates LP	37,453	$1.62M	0.1%	+0.7%	0.066%
8/14/2024	Marshall Wace LLP	1,133,735	$48.89M	0.1%	+307.8%	1.997%
8/14/2024	Farallon Capital Management LLC	5,654,502	$243.82M	1.2%	+1.1%	9.960%
8/14/2024	ProShare Advisors LLC	10,944	$0.47M	0.0%	-21.4%	0.019%
8/14/2024	Profund Advisors LLC	14,773	$0.64M	0.0%	-57.4%	0.026%
8/13/2024	Thrivent Financial for Lutherans	24,603	$1.06M	0.0%	-4.1%	0.043%
8/13/2024	Sei Investments Co.	23,378	$1.01M	0.0%	N/A	0.041%
8/13/2024	Public Employees Retirement Association of Colorado	6,796	$0.29M	0.0%	-30.6%	0.012%
8/12/2024	Inspire Investing LLC	8,115	$0.35M	0.0%	-33.5%	0.014%
8/12/2024	XTX Topco Ltd	5,333	$0.23M	0.0%	N/A	0.009%
8/12/2024	Seven Eight Capital LP	39,262	$1.69M	0.2%	N/A	0.069%
8/12/2024	Hsbc Holdings PLC	5,987	$0.26M	0.0%	-12.7%	0.011%
8/12/2024	E Fund Management Co. Ltd.	4,668	$0.20M	0.0%	-55.3%	0.008%
8/9/2024	Edgestream Partners L.P.	42,076	$1.81M	0.1%	N/A	0.074%
8/9/2024	Dimensional Fund Advisors LP	2,196,085	$94.70M	0.0%	-14.8%	3.868%
8/8/2024	Federated Hermes Inc.	13,394	$0.58M	0.0%	+9.0%	0.024%
8/8/2024	American Century Companies Inc.	94,486	$4.07M	0.0%	+17.2%	0.166%
8/8/2024	State of New Jersey Common Pension Fund D	48,943	$2.11M	0.0%	-42.3%	0.086%
8/7/2024	Headlands Technologies LLC	11,450	$0.49M	0.1%	N/A	0.020%
8/6/2024	Quest Partners LLC	919	$40K	0.0%	N/A	0.002%
8/6/2024	Acadian Asset Management LLC	864	$37K	0.0%	N/A	0.002%
8/6/2024	Candriam S.C.A.	322,882	$13.92M	0.1%	N/A	0.569%
8/6/2024	North Star Asset Management Inc.	5,000	$0.22M	0.0%	N/A	0.009%
8/5/2024	Arizona State Retirement System	14,159	$0.61M	0.0%	-7.8%	0.025%
8/3/2024	TD Asset Management Inc	210,472	$9.08M	0.0%	+34.6%	0.371%
8/1/2024	Rhumbline Advisers	101,180	$4.36M	0.0%	-0.9%	0.178%
7/30/2024	BNP PARIBAS ASSET MANAGEMENT Holding S.A.	911,175	$39.29M	0.1%	-17.8%	1.605%
7/29/2024	Principal Financial Group Inc.	7,594	$0.33M	0.0%	-43.5%	0.013%
7/29/2024	Panagora Asset Management Inc.	174,870	$7.54M	0.0%	N/A	0.308%
7/26/2024	Bank of New York Mellon Corp	223,151	$9.62M	0.0%	+13.9%	0.393%
7/25/2024	Northcape Wealth Management LLC	5,670	$0.24M	0.1%	N/A	0.010%
7/18/2024	Assenagon Asset Management S.A.	134,980	$5.82M	0.0%	-70.3%	0.238%
7/17/2024	Oak Ridge Investments LLC	35,236	$1.52M	0.1%	-12.0%	0.062%
7/9/2024	Harbor Capital Advisors Inc.	32,770	$1.41M	0.1%	+70.0%	0.058%
5/24/2024	Farallon Capital Management LLC	5,590,602	$163.47M	0.7%	+34.1%	9.848%
5/17/2024	Tidal Investments LLC	32,336	$0.95M	0.0%	N/A	0.057%
5/16/2024	California State Teachers Retirement System	55,837	$1.63M	0.0%	-5.0%	0.098%
5/16/2024	Kennedy Capital Management LLC	159,288	$4.66M	0.1%	N/A	0.281%
5/16/2024	Caxton Associates LP	37,189	$1.09M	0.1%	N/A	0.066%
5/15/2024	Public Employees Retirement Association of Colorado	9,799	$0.29M	0.0%	-8.3%	0.017%
5/15/2024	Bellevue Group AG	4,006,000	$117.14M	1.8%	-0.1%	7.057%
5/15/2024	Price T Rowe Associates Inc. MD	2,012,993	$58.86M	0.0%	+23.9%	3.546%
5/15/2024	Altitude Crest Partners Inc.	113,100	$3.31M	1.4%	N/A	0.199%
5/14/2024	EntryPoint Capital LLC	2,924	$85K	0.1%	-15.5%	0.005%
5/14/2024	CANADA LIFE ASSURANCE Co	31,144	$0.91M	0.0%	+1.8%	0.055%
5/10/2024	Vanguard Group Inc.	5,572,021	$162.93M	0.0%	+0.8%	9.815%
5/9/2024	State Board of Administration of Florida Retirement System	18,017	$0.53M	0.0%	+13.7%	0.032%
5/8/2024	BNP PARIBAS ASSET MANAGEMENT Holding S.A.	1,108,613	$32.42M	0.1%	+5.9%	1.953%
5/8/2024	Entropy Technologies LP	9,787	$0.29M	0.0%	N/A	0.017%

Data available starting January 2016

Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias. The company develops AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias; and AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria. Its preclinical product is siRNA for the treatment of polycythemia vera, a rare blood disorder. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $59.10

$56.67

$59.61

50 Day Range

MA: $47.66

$40.50

$60.46

52 Week Range

Now: $59.10

$20.96

$62.58

Volume

484,587 shs

Average Volume

697,306 shs

Market Capitalization

$3.37 billion

P/E Ratio

5.20

Dividend Yield

N/A

Beta

0.75

Who are the company insiders with the largest holdings of Agios Pharmaceuticals?: Agios Pharmaceuticals' top insider shareholders include:
Jacqualyn A Fouse (Director)
David P Schenkein (Director)
Brian Goff (CEO)
James William Burns (Insider)
Sarah Gheuens (Insider)
Cecilia Jones (CFO)
Kaye I Foster-Cheek (Director)
Tsveta Milanova (Insider)
Theodore James Jr Washburn (Insider)
Learn More about top insider investors at Agios Pharmaceuticals.
Who are the major institutional investors of Agios Pharmaceuticals?: Agios Pharmaceuticals' top institutional shareholders include:
Bellevue Group AG — 6.55%
State Street Corp — 4.09%
Erste Asset Management GmbH — 3.83%
Geode Capital Management LLC — 2.38%
Frazier Life Sciences Management L.P. — 1.83%
BNP PARIBAS ASSET MANAGEMENT Holding S.A. — 1.59%
Learn More about top institutional investors of Agios Pharmaceuticals stock.
Which major investors are selling Agios Pharmaceuticals stock?: Within the previous quarter, AGIO stock was sold by these institutional investors:
Parkman Healthcare Partners LLC
Bellevue Group AG
ArrowMark Colorado Holdings LLC
Assenagon Asset Management S.A.
PDT Partners LLC
Connor Clark & Lunn Investment Management Ltd.
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Wellington Management Group LLP
In the previous year, company insiders that have sold Agios Pharmaceuticals company stock include:
Jacqualyn A Fouse (Director)
David P Schenkein (Director)
Brian Goff (CEO)
James William Burns (Insider)
Sarah Gheuens (Insider)
Cecilia Jones (CFO)
Kaye I Foster-Cheek (Director)
Tsveta Milanova (Insider)
Learn More investors selling Agios Pharmaceuticals stock.
Which major investors are buying Agios Pharmaceuticals stock?: In the last quarter, AGIO stock was acquired by institutional investors including:
Erste Asset Management GmbH
Vestal Point Capital LP
State Street Corp
Frazier Life Sciences Management L.P.
Loomis Sayles & Co. L P
Fisher Asset Management LLC
Summit Partners Public Asset Management LLC
Caligan Partners LP